The University of Iowa
College of Liberal Arts and Sciences
The Department of Biology

Faculty Information

Christopher Stipp

Christopher Stipp

Associate Professor
Ph.D., Massachusetts Institute of Technology 1996
236 BBE
(319) 335-0192
Printable PDF Version

Cell Surface Interaction Maps, Cell Migration, & Mechanisms of Integrin Functional Diversity

Cues in the extracellular microenvironment govern the behavior of migrating cells by triggering changes in migration speed or direction. The cell surface receptors that interpret these cues engage cytoplasmic partners to transduce signals, but recent work reveals that many receptors also interact laterally with cell surface proteins that can be critical for proper receptor function. Thus, a more sophisticated understanding of cell migration will require a "cell surface interaction map" describing the physical and functional connections between receptors and their cell surface partners.

To begin to build such an interaction map, we have initially focused on integrins, the major receptors for extracellular matrix proteins. Integrins mediate cell adhesion and migration during development, in homeostasis, and in a variety of pathological settings, including tumor cell metastasis. Integrins are heterodimers composed of one α and one β subunit. While both subunits contribute to ligand-binding specificity, the β subunit cytoplasmic tail mediates most of the established integrin signaling and cytoskeletal interactions that have been identified. Thus at present there is no satisfactory explanation for how different integrins that share a common β subunit are able to mediate different cellular responses. For example, tumor cell motility mediated by α3β1 integrin on its ligand, laminin-332 (laminin-5), can be 3-4 fold faster than motility mediated by other β1 integrins, such as the collagen receptor, α2β1, or the fibronectin receptor, α5β1.

We hypothesize that the diversity in the functions of different β1 integrins may derive in part from their differing patterns of lateral cell surface interactions. Our earlier studies helped to establish that α3β1 integrin is distinguished from other β1 integrins, such as α2β1 and α5β1, by its ability to avidly engage in complexes with members of the tetraspanin family of cell surface adaptor proteins. Tetraspanins, so named because of their four transmembrane domains, are a large family of proteins known for their ability to assemble multi-protein cell surface complexes. Integrin α3β1 strongly interacts with one particular tetraspanin, CD151, which in turn links α3β1 into larger cell surface complexes that may contain other tetraspanins, Ig superfamily (IgSF) proteins, growth factor receptors, membrane-bound growth factors, and novel proteins (Figure 1). Currently, a major focus in the lab is determining (i) the extent to which assembly into tetraspanin complexes can help to explain α3β1 integrin’s ability to mediate unusually rapid tumor cell migration, and (ii) the implications of tetraspanin association for the role of α3β1 in metastatic tumor cell spread. We are employing an array of complementary approaches to address these questions including:

  1. Silencing specific tetraspanins by RNA interference to determine their individual contributions to α3β1-dependent tumor cell motility,
  2. Reconstituting tetraspanin-silenced cells with mutant tetraspanins that lack specific interaction domains,
  3. Silencing specific integrins to compare outright loss of integrin function to the more subtle modulation of function that is possible by manipulating tetraspanins,
  4. Testing our tetraspanin and integrin mutant cells in high resolution time-lapse video-microscopy, adhesion, proliferation, and 3D invasion assays (see Figure 2),
  5. Studying the biochemical association, trafficking, and signaling properties of integrins in tumor cells lacking specific tetraspanins or expressing tetraspanin mutants,
  6. Developing in vivo assays of metastatic colonization using bioluminescence imaging to monitor tumor growth in real time in live animals (see Figure 3).

Another form of integrin functional diversity is the ability of individual integrins to mediate different responses in different cell types. For example, integrin α3β1 is implicated in promoting the growth and invasion of some tumor cell types, but in acting as a suppressor in the progression of other tumor types. Here again, α3β1's association with tetraspanins may provide potential answers. We recently discovered that, in addition to regulating α3β1 integrin's migratory functions (Figure 2), tetraspanin CD151 also contributes to α3β1's ability to promote stable cell-cell junctions in epithelial tumor cells (Figure 4). By mechanisms that we are still unraveling, α3β1 integrin appears to generate signaling that helps to promote stable cell-cell junctions among tumor cells, and this junction-stabilizing function may oppose α3β1’s pro-migratory functions. Therefore, a second major focus in our lab is to determine how tetraspanins regulate the balance between α3β1 integrin's pro- and anti-migratory functions and how this relates to the dual roles of α3β1 in regulating metastasis.

A third focus in the lab is the role of integrins and integrin-tetraspanin complexes in neuronal cell behavior. Here, we are exploring the extent to which differing patterns of integrin expression in central versus peripheral neurons may help to explain differences in their respective abilities to regenerate after injury. For example, injured peripheral neurons upregulate α5β1 integrin and may use it to respond to the α5β1 ligand, fibronectin, which also accumulates at injury sites. In contrast, central neurons generally express low levels of α5β1 and respond poorly to fibronectin. We recently found that enforced expression of α5β1 can dramatically enhance the ability of a central nervous system neuronal cell type to respond to fibronectin in an in vitro model of regenerative outgrowth (Figure 5). Future directions for this project include evaluating the ability of α5β1 to promote regenerative outgrowth in in vivo models, and exploring how tetraspanins may contribute to the differential sensitivity of outgrowth on different integrin ligands to physiological inhibitors that may be present at injury sites.

Click on a thumbnail to view image and description:
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Selected Publications

Stipp CS. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med. 2010 Jan 18;12:e3.

Meland MN, Herndon ME, Stipp CS. Expression of alpha5 integrin rescues fibronectin responsiveness in NT2N CNS neuronal cells. J Neurosci Res. 2009 Jul 13. [Epub ahead of print] (

Johnson JL, Winterwood N, Demali KA, Stipp CS. Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts. J Cell Sci. 2009 Jul 1;122(Pt 13):2263-73. Epub 2009 Jun 9. (

Bari R, Zhang YH, Zhang F, Wang NX, Stipp CS, Zheng JJ, Zhang XA. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol. 2009 Feb;174(2):647-60. Epub 2008 Dec 30.

Winterwood NE, Varzavand A, Meland MN, Ashman LK, Stipp CS. A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5. Mol Biol Cell. 2006 Jun;17(6):2707-21. (

Kiener HP, Stipp CS, Allen PG, Higgins JM, Brenner MB. The cadherin-11 cytoplasmic juxtamembrane domain promotes alpha-catenin turnover at adherens junctions and intercellular motility. Mol Biol Cell. 2006 May;17(5):2366-76. Epub 2006 Mar 8.

Wunschmann S, Muller HM, Stipp CS, Hemler ME, Stapleton JT. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. J Infect Dis. 2006 Oct 15;194(8):1058-67. Epub 2006 Sep 8.

Little KD, Hemler ME, Stipp CS. Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell. 2004 May;15(5):2375-87. (

Kolesnikova TV, Stipp CS, Rao RM, Lane WS, Luscinskas FW, Hemler ME. EWI-2 modulates lymphocyte integrin alpha4beta1 functions. Blood. 2004 Apr 15;103(8):3013-9. Epub 2003 Dec 18.

Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol. 2004 Dec 20;167(6):1231-40.

Stipp CS, Kolesnikova TV, Hemler ME. EWI-2 regulates a3b1 integrin-dependent cell functions on laminin-5. J Cell Biol. 2003 Dec 8;163(5):1167-77. (

Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin proteins. Trends Biochem Sci 2003. 28(2):106-12.

Kazarov AR, Yang X, Stipp CS, Sehgal B, Hemler ME. An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol. 2002 Sep 30;158(7):1299-309.

Zhang XA, Kazarov AR, Yang X, Bontrager AL, Stipp CS, Hemler ME. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell. 2002 Jan;13(1):1-11.

Stipp CS, Kolesnikova TV, Hemler ME. EWI-2 is a major CD9 and CD81 partner, and member of a novel Ig protein subfamily. J Biol Chem 2001; 276:40545-54.

Stipp CS, Orlicky D, Hemler ME. FPRP: A major, highly stoichiometric, highly specific CD81 and CD9-associated protein. J Biol Chem 2001;276:4853-62.

Claas C, Stipp CS, Hemler ME. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem. 2001 Mar 16;276(11):7974-84. Epub 2000 Dec 11.

Zhang XA, Bontrager AL, Stipp CS, Kraeft SK, Bazzoni G, Chen LB, Hemler ME. Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement. Mol Biol Cell. 2001 Feb;12(2):351-65.

Stipp CS, Hemler ME. Transmembrane-4-superfamily proteins CD151 and CD81 associate with a3b1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci. 2000. 114:1871-1882